Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Issue Archive
Events
MM&M Awards 2012
Webcasts
MM&M Virtual Summit
Whitepapers
Directories
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
MMM
>
News
> Drugs.com defects to WebMD
Drugs.com defects to WebMD
Marc Iskowitz
November 11, 2009
Print
Email
Reprint
Permissions
Text:
A
|
A
|
A
Drugs.com is aligning with its current network's rival
Related Articles
WebMD closes in on Everyday Health: comScore
More News
Komen, caught up in the culture wars, nurses damaged brand
Allergan scrubs some doc-payment data, spares med-ed grants
Jobson Medical files for chapter 11 debt relief
Merck results buoyed by sales of Januvia franchise
AstraZeneca announces more layoffs, Q4 results
RELATED TOPICS
Business
Digital
Media
Online
Drugs.com, a free online drug-information database, will join the WebMD Health Network starting Jan. 1, said WebMD.
Drugs.com is presently a member of the Everyday Health Network. The shift means the site's monthly visitors, now counted toward the total unique-visitor traffic for Everyday Health, will soon be added to WebMD's tally. As of September, Drugs.com had 4.8 million unique monthly visitors, an increase of 36% vs. September 2008, according to online audience-measurement firm comScore.
“With Drugs.com in WebMD's network, we will be providing the pharmaceutical industry with the largest audience of target consumers and patients seeking product-related information,” said a WebMD spokesperson.
The two networks have been in a close race for traffic. Everyday Health surpassed WebMD a year ago to lead the online consumer health space, following its acquisition of Revolution Health. But an April report in MM&M, citing comScore figures, noted that WebMD had pulled within one million unique visitors of its rival.
The pact also gives WebMD exclusive control over Drugs.com's pharmaceutical and other advertising inventory, WebMD said. Since 2007 the site's advertising representation has been handled by Waterfront Media, the publisher of Everyday Health Network.
"Everyday Health had a tremendous 2009, averaging 20-25 million unique visitors a month," said CEO Ben Wolin. "Additionally, over 30 million consumers are now Everyday Health registered users. We expect our audience and database to continue growing throughout 2010 as we continue to improve and evolve the composition of our portfolio sites."
Drugs.com, which is owned and operated by a privately held trust administered by two New Zealand pharmacists, will retain control of its content, the spokesperson said. The site provides free information on more than 24,000 prescription, OTC and natural products, along with a pill identifier, drug-interaction checker, illustrated health encyclopedia and online medical dictionary.
Please enable JavaScript to view the
comments powered by Disqus.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MM&M Awards Photos
Most Popular
Most Emailed
Most Recent
Elsevier begins outreach as push-back on publisher threatens to widen
Bydureon approval a shot across bow for Victoza
P&G signals plans to cut ad costs by shifting to digital media
Jobson Medical files for chapter 11 debt relief
Patient Education: Vying for Attention
FDA study casts doubt on danger of "distracting visuals"
Generics makers approach a cliff of their own
MM&M Therapeutic Focus: Cardiovascular
AstraZeneca announces more layoffs, Q4 results
DDR on DTC: Spiriva
Jobson Medical files for chapter 11 debt relief
Elsevier begins outreach as push-back on publisher threatens to widen
P&G signals plans to cut ad costs by shifting to digital media
Bydureon approval a shot across bow for Victoza
Generics makers approach a cliff of their own
Merck results buoyed by sales of Januvia franchise
FDA study casts doubt on danger of "distracting visuals"
Allergan scrubs some doc-payment data, spares med-ed grants
MM&M Therapeutic Focus: Cardiovascular
Ernst & Young's Buck Luce named HBA Woman of the Year
Komen, caught up in the culture wars, nurses damaged brand
Allergan scrubs some doc-payment data, spares med-ed grants
Jobson Medical files for chapter 11 debt relief
A new test to identify Down Syndrome
Making a political football out of Plan B
Med Ed Report briefs
Merck results buoyed by sales of Januvia franchise
AstraZeneca announces more layoffs, Q4 results
Docs, patients and pharma
Ernst & Young's Buck Luce named HBA Woman of the Year
Popular Topics
Adherence
Advertising
Approval
Brand
CME
Companion Diagnostics
Corporate Reputation
DDMAC
Digital
Direct To Consumer (DTC)
DTC
Earnings
FDA
Financial
Generic
Guidance
Launch
Loyalty Program
Magazine
Major Statement
Manufacturing
Med Ed
Media
Regulatory
Television